169 related articles for article (PubMed ID: 16455260)
1. Effective discrimination of antimalarial potency of artemisinin compounds based on quantum chemical calculations of their reaction mechanism.
Tonmunphean S; Parasuk V; Kokpol S
Bioorg Med Chem; 2006 Apr; 14(7):2082-8. PubMed ID: 16455260
[TBL] [Abstract][Full Text] [Related]
2. Antimalarial activities of (+)-deoxoartemisitene and its novel C-11, 13 derivatives.
Jung M; Lee K; Jung H; Kendrick H; Yardley V; Croft SL
Bioorg Med Chem Lett; 2004 Apr; 14(8):2001-3. PubMed ID: 15050646
[TBL] [Abstract][Full Text] [Related]
3. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimalarial activity of ethylene glycol oligomeric ethers of artemisinin.
Steyn M; N'Da DD; Breytenbach JC; Smith PJ; Meredith S; Breytenbach WJ
J Pharm Pharmacol; 2011 Feb; 63(2):278-86. PubMed ID: 21235593
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P. falciparum malaria parasites and HL-60 cancer cells.
Chadwick J; Mercer AE; Park BK; Cosstick R; O'Neill PM
Bioorg Med Chem; 2009 Feb; 17(3):1325-38. PubMed ID: 19136263
[TBL] [Abstract][Full Text] [Related]
6. Quantum chemical study of the intermediate complex required for iron-mediated reactivity and antimalarial activity of dispiro-1,2,4-trioxolanes.
Creek DJ; Chalmers DK; Charman WN; Duke BJ
J Mol Graph Model; 2008 Oct; 27(3):394-400. PubMed ID: 18693050
[TBL] [Abstract][Full Text] [Related]
7. Antitumour and antimalarial activity of artemisinin-acridine hybrids.
Jones M; Mercer AE; Stocks PA; La Pensée LJ; Cosstick R; Park BK; Kennedy ME; Piantanida I; Ward SA; Davies J; Bray PG; Rawe SL; Baird J; Charidza T; Janneh O; O'Neill PM
Bioorg Med Chem Lett; 2009 Apr; 19(7):2033-7. PubMed ID: 19249201
[TBL] [Abstract][Full Text] [Related]
8. Rationale design of biotinylated antimalarial endoperoxide carbon centered radical prodrugs for applications in proteomics.
Barton V; Ward SA; Chadwick J; Hill A; O'Neill PM
J Med Chem; 2010 Jun; 53(11):4555-9. PubMed ID: 20476788
[TBL] [Abstract][Full Text] [Related]
9. Facile oxidation of leucomethylene blue and dihydroflavins by artemisinins: relationship with flavoenzyme function and antimalarial mechanism of action.
Haynes RK; Chan WC; Wong HN; Li KY; Wu WK; Fan KM; Sung HH; Williams ID; Prosperi D; Melato S; Coghi P; Monti D
ChemMedChem; 2010 Aug; 5(8):1282-99. PubMed ID: 20629071
[TBL] [Abstract][Full Text] [Related]
10. Reactions of artemisinin and arteether with acid: implications for stability and mode of antimalarial action.
Drew MG; Metcalfe J; Dascombe MJ; Ismail FM
J Med Chem; 2006 Oct; 49(20):6065-73. PubMed ID: 17004720
[TBL] [Abstract][Full Text] [Related]
11. Fluoroartemisinin: trifluoromethyl analogues of artemether and artesunate.
Magueur G; Crousse B; Charneau S; Grellier P; Bégué JP; Bonnet-Delpon D
J Med Chem; 2004 May; 47(10):2694-9. PubMed ID: 15115411
[TBL] [Abstract][Full Text] [Related]
12. Fluoroartemisinins: metabolically more stable antimalarial artemisinin derivatives.
Bégué JP; Bonnet-Delpon D
ChemMedChem; 2007 May; 2(5):608-24. PubMed ID: 17252616
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel C-9 carbon substituted derivatives of artemisinin.
Meyer D; Smeilus T; Pliatsika D; Mousavizadeh F; Giannis A
Bioorg Med Chem; 2017 Nov; 25(22):6098-6101. PubMed ID: 28341405
[TBL] [Abstract][Full Text] [Related]
14. Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy.
Posner GH; Paik IH; Sur S; McRiner AJ; Borstnik K; Xie S; Shapiro TA
J Med Chem; 2003 Mar; 46(6):1060-5. PubMed ID: 12620083
[TBL] [Abstract][Full Text] [Related]
15. Antimalarial activity: a QSAR modeling using CODESSA PRO software.
Katritzky AR; Kulshyn OV; Stoyanova-Slavova I; Dobchev DA; Kuanar M; Fara DC; Karelson M
Bioorg Med Chem; 2006 Apr; 14(7):2333-57. PubMed ID: 16426851
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel 10-deoxoartemisinins.
Khac VT; Van TN; Van ST
Bioorg Med Chem Lett; 2005 May; 15(10):2629-31. PubMed ID: 15863331
[TBL] [Abstract][Full Text] [Related]
17. Influence of stereoisomer of dispiro-1,2,4,5-tetraoxanes on their binding mode with heme and on antimalarial activity: molecular docking studies.
Tonmunphean S; Wijitkosoom A; Tantirungrotechai Y
Bioorg Med Chem; 2004 May; 12(9):2005-12. PubMed ID: 15080904
[TBL] [Abstract][Full Text] [Related]
18. Identification of a 1,2,4,5-tetraoxane antimalarial drug-development candidate (RKA 182) with superior properties to the semisynthetic artemisinins.
O'Neill PM; Amewu RK; Nixon GL; Bousejra ElGarah F; Mungthin M; Chadwick J; Shone AE; Vivas L; Lander H; Barton V; Muangnoicharoen S; Bray PG; Davies J; Park BK; Wittlin S; Brun R; Preschel M; Zhang K; Ward SA
Angew Chem Int Ed Engl; 2010 Aug; 49(33):5693-7. PubMed ID: 20629058
[No Abstract] [Full Text] [Related]
19. Peroxide bond strength of antimalarial drugs containing an endoperoxide cycle. Relation with biological activity.
Fernández I; Robert A
Org Biomol Chem; 2011 Jun; 9(11):4098-107. PubMed ID: 21487624
[TBL] [Abstract][Full Text] [Related]
20. Artemisinins: mechanisms of action and potential for resistance.
Krishna S; Uhlemann AC; Haynes RK
Drug Resist Updat; 2004; 7(4-5):233-44. PubMed ID: 15533761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
